Case number 2019-1364
Biogen, Inc. v. Hirshfeld > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | BIOGEN, INC. v. IANCU [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Feb 8, 2021 | 69 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [754557] [JCP] [Entered: 02/08/2021 03:41 PM] (0) |
| Jan 22, 2021 | 68 | Official caption revised to reflect Andrew Hirshfeld, Performing the Functions and Duties of the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, as intervenor (see attached). Service as of this date by the Clerk of Court. [751070] [JAL] [Entered: 01/22/2021 02:07 PM] (0) |
| Dec 16, 2020 | 67 | JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [743086] [JAB] [Entered: 12/16/2020 09:31 AM] (0) |
| Oct 27, 2020 | 65 | Notice from Appellant Biogen, Inc. of Withdrawal of Counsel. Service: 10/27/2020 by email. [731591] [19-1364] [Brian Schmalzbach] [Entered: 10/27/2020 10:18 AM] (0) |
| Oct 27, 2020 | 66 | Notice from Appellant Biogen, Inc. of Withdrawal of Counsel. Service: 10/27/2020 by email. [731593] [19-1364] [Lyle Kossis] [Entered: 10/27/2020 10:21 AM] (0) |
| Oct 22, 2020 | 64 | Amended Entry of appearance for Wanda D. French-Brown as counsel for Appellant Biogen, Inc.. Service: 10/22/2020 by email. [730775] [19-1364] [Wanda French-Brown] [Entered: 10/22/2020 10:36 AM] (0) |
| Dec 6, 2019 | 63 | Submitted after ORAL ARGUMENT by Ms. Wanda Deloris French-Brown, Esq. for Biogen, Inc. and Sarah E. Craven for Iancu. Panel: Judge: Newman , Judge: Moore , Judge: Chen. [654515] [JCP] [Entered: 12/06/2019 10:18 AM] (0) |
| Oct 28, 2019 | 62 | Response to notice of oral argument from the Intervenor Iancu. [644996] [19-1364] [Sarah Craven] [Entered: 10/28/2019 09:26 AM] (0) |
| Oct 23, 2019 | 61 | Response to notice of oral argument from the Appellant Biogen, Inc.. [644263] [19-1364] [Wanda French-Brown] [Entered: 10/23/2019 04:25 PM] (0) |
| Oct 21, 2019 | 60 | NOTICE OF ORAL ARGUMENT. Panel: 1912O. Case scheduled December 6, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 11/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [643564] [JAB] [Entered: 10/21/2019 03:47 PM] (0) |
| Oct 11, 2019 | 59 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Biogen, Inc.. Service: 10/11/2019 by email. [641928] [19-1364] [Wanda French-Brown] [Entered: 10/11/2019 03:56 PM] (24) |
| Aug 26, 2019 | 58 | The following conflict dates submitted by Attorney Wanda Deloris French-Brown for Appellant Biogen, Inc. have been accepted by the court: 11/04/2019, 11/05/2019, 11/06/2019, 11/07/2019, 11/08/2019. [630948] [JAB] [Entered: 08/26/2019 12:48 PM] (0) |
| Aug 26, 2019 | 57 | Letter from Appellant Biogen, Inc. Letter regarding good cause for oral argument conflicts. Service: 08/26/2019 by email. [630848] [19-1364] [Wanda French-Brown] [Entered: 08/26/2019 10:00 AM] (2) |
| Aug 26, 2019 | 56 | Notice from Appellant Biogen, Inc. regarding conflicts with oral argument. Service: 08/26/2019 by email. [630844] [19-1364] [Wanda French-Brown] [Entered: 08/26/2019 09:57 AM] (2) |
| Aug 21, 2019 | 55 | ORDER filed. Attorney Rachelle H. Thompson is hereby substituted with Attorney Wanda French-Brown. Biogen, Inc. is directed to file an updated notice of conflicts within seven days. Service as of this date by the Clerk of Court. [630052] [MMA] [Entered: 08/21/2019 04:29 PM] (2) |
| Aug 19, 2019 | 54 | MOTION of Appellant Biogen, Inc. to withdraw counsel Rachelle H. Thompson, and Alter Oral Argument Availability [Consent: unopposed]. Service: 08/19/2019 by email. [629175] [19-1364] [Wanda French-Brown] [Entered: 08/19/2019 10:29 AM] (4) |
| Aug 19, 2019 | 53 | Entry of appearance for Wanda D. French-Brown as principal counsel for Appellant Biogen, Inc.. Service: 08/19/2019 by email. [629166] [19-1364] [Wanda French-Brown] [Entered: 08/19/2019 10:17 AM] (1) |
| Jul 19, 2019 | 52 | The following conflict dates submitted by Attorney Rachelle Harley Thompson for Appellant Biogen, Inc. have been accepted by the court: 09/03/2019, 09/04/2019, 09/05/2019, 09/06/2019, 10/01/2019, 10/02/2019, 10/03/2019, 11/07/2019, 11/08/2019. [622207] [JAB] [Entered: 07/19/2019 12:51 PM] (0) |
| Jul 19, 2019 | 51 | Letter from Appellant Biogen, Inc. Letter regarding good cause for oral argument conflicts. Service: 07/19/2019 by email. [622183] [19-1364] [Rachelle Thompson] [Entered: 07/19/2019 11:51 AM] (2) |
| Jul 19, 2019 | 50 | Notice from Appellant Biogen, Inc. regarding conflicts with oral argument. Service: 07/19/2019 by email. [622181] [19-1364] [Rachelle Thompson] [Entered: 07/19/2019 11:49 AM] (2) |
| Jul 17, 2019 | 49 | 6 paper copies of the Intervenor Brief [38] received from Intervenor Iancu. [621674] [CJF] [Entered: 07/17/2019 12:19 PM] (0) |
| Jul 17, 2019 | 48 | 6 paper copies of the Opening Brief [32] received from Appellant Biogen, Inc.. [621617] [CJF] [Entered: 07/17/2019 11:12 AM] (0) |
| Jul 17, 2019 | 47 | 6 paper copies of the Reply Brief [39] received from Appellant Biogen, Inc.. [621615] [CJF] [Entered: 07/17/2019 11:11 AM] (0) |
| Jul 17, 2019 | 46 | 6 paper copies of the Corrected Appendix Brief [43] received from Appellant Biogen, Inc. and Intervenor Iancu. [621614] [CJF] [Entered: 07/17/2019 11:10 AM] (0) |
| Jul 12, 2019 | 45 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [620518] [MMA] [Entered: 07/12/2019 10:21 AM] (1) |
| Jul 12, 2019 | 44 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [620517] [MMA] [Entered: 07/12/2019 10:20 AM] (0) |
| Jul 11, 2019 | 43 | MODIFIED ENTRY: CORRECTED APPENDIX FILED for Biogen, Inc. and Iancu. Number of Pages: 340. Service: 07/12/2019 by email. [620390]--[Edited 07/12/2019 by MMA - Reason: compliance review complete] [Rachelle Thompson] [Entered: 07/11/2019 03:46 PM] (340) |
| Jul 11, 2019 | 42 | Notice of Correction to the Brief Doc No. [40] for Appellant Biogen, Inc.. Service: 07/11/2019 by email. [620386] [19-1364] [Rachelle Thompson] [Entered: 07/11/2019 03:42 PM] (3) |
| Jul 5, 2019 | 41 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Biogen, Inc. and Intervenor Iancu, Joint Appendix [40], is not in compliance with the rules of this court (see attached). Compliant appendix due on 07/12/2019. Service as of this date by the Clerk of Court. [619297] [MMA] [Entered: 07/05/2019 03:09 PM] (1) |
| Jul 3, 2019 | 40 | FILED from Appellant Biogen, Inc. and Intervenor Iancu. Title: JOINT APPENDIX. Service: 07/03/2019 by email. [618957] [19-1364] This appendix is non-compliant. See Doc. No. [41] [Rachelle Thompson] [Entered: 07/03/2019 02:16 PM] (346) |
| Jun 27, 2019 | 39 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Biogen, Inc. Number of Pages: 30. Service: 06/27/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [617610] --[Edited 07/01/2019 by MMA - Reason: compliance review complete] [Rachelle Thompson] [Entered: 06/27/2019 08:22 PM] (37) |
| Jun 6, 2019 | 38 | MODIFIED ENTRY: BRIEF FILED for Intervenor Iancu. Number of Pages: 31. Service: 06/06/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [612158] --[Edited 06/07/2019 by MMA - Reason: compliance review complete] [Sarah Craven] [Entered: 06/06/2019 03:42 PM] (41) |
| Jun 6, 2019 | 37 | Entry of appearance for Robert J. McManus as of counsel for Intervenor Iancu. Service: 06/06/2019 by email. [612152] [19-1364] [Robert McManus] [Entered: 06/06/2019 03:30 PM] (2) |
| Jun 6, 2019 | 36 | Docketing Statement for the Intervenor Iancu. Service: 06/06/2019 by email. [612137] [19-1364] [Sarah Craven] [Entered: 06/06/2019 03:10 PM] (3) |
| Jun 5, 2019 | 35 | ORDER filed. The motion [33] is granted to the extent that the Director replaces the United States as an intervenor. The revised official caption and short caption are reflected in this order. The Director’s brief is due no later than 40 days from the date of filing of this order. The appellant’s reply brief is due 21 days thereafter. Service: 06/05/2019 by clerk. [611837] [NL] [Entered: 06/05/2019 04:22 PM] (2) |
| May 6, 2019 | 34 | Entry of appearance for Frances M. Lynch as of counsel for Director, U.S. Patent and Trademark Office. Service: 05/06/2019 by email. [605208] [19-1364] [Frances Lynch] [Entered: 05/06/2019 02:18 PM] (2) |
| May 2, 2019 | 33 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 05/02/2019 by email. [604729] [19-1364] [Sarah Craven] [Entered: 05/02/2019 03:35 PM] (3) |
| Apr 15, 2019 | 32 | MODIFIED ENTRY: BRIEF FILED for Appellant Biogen, Inc. Number of Pages: 64. Service: 04/15/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [600371] --[Edited 04/16/2019 by MMA - Reason: compliance review complete] [Rachelle Thompson] [Entered: 04/15/2019 09:20 PM] (134) |
| Apr 9, 2019 | 31 | ORDER granting motion to withdraw document [30]. Service as of this date by the Clerk of Court. [598663] [MMA] [Entered: 04/09/2019 11:23 AM] (2) |
| Apr 8, 2019 | 30 | MOTION of Director of the United States Patent and Trademark Office to withdraw [29] party notice [Consent: not addressed]. Service: 04/08/2019 by email. [598537] [19-1364] [Sarah Craven] [Entered: 04/08/2019 05:50 PM] (3) |
| Apr 8, 2019 | 29 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 04/08/2019 by email. [598513] [19-1364] This document has been withdrawn. See Doc. No. [31] [Sarah Craven] [Entered: 04/08/2019 04:13 PM] (3) |
| Mar 29, 2019 | 26 | ORDER filed. The revised official caption and short caption are reflected in this order. Service: 03/29/2019 by clerk. [596521] [LMS] [Entered: 03/29/2019 01:08 PM] (2) |
| Mar 29, 2019 | 28 | Corrected Entry of appearance for Dennis Fan as principal counsel for Intervenor US. Service: 03/29/2019 by email. [596544] [19-1364] [Dennis Fan] [Entered: 03/29/2019 01:54 PM] (1) |
| Mar 29, 2019 | 27 | NOTICE OF NON-COMPLIANCE: The submission of Intervenor US, Entry of Appearance - D. Fan [24], is not in compliance with the rules of this court (see attached). Compliant document due on 04/05/2019. Service as of this date by the Clerk of Court.[596532] [MMA] [Entered: 03/29/2019 01:31 PM] (1) |
| Mar 29, 2019 | 25 | Entry of appearance for Sarah E. Craven as of counsel for United States. Service: 03/29/2019 by email. [596403] [19-1364] [Sarah Craven] [Entered: 03/29/2019 09:22 AM] (2) |
| Mar 21, 2019 | 24 | Entry of appearance for Dennis Fan as principal counsel for United States. Service: 03/21/2019 by email. [594745] [19-1364] This document is non-compliant. See Doc. No. [27] [Dennis Fan] [Entered: 03/21/2019 04:51 PM] (1) |
| Mar 21, 2019 | 23 | MOTION of United States for leave to intervene [Consent: not addressed]. Service: 03/21/2019 by email. [594743] [19-1364] [Dennis Fan] [Entered: 03/21/2019 04:50 PM] (4) |
| Mar 20, 2019 | 22 | Letter from Appellee Pfizer, Inc. Notice of non-participation in appeal, brief will not be filed. Service: 03/20/2019 by email. [594106] [19-1364] [John Scheibeler] [Entered: 03/20/2019 10:00 AM] (2) |
| Feb 27, 2019 | 21 | ORDER filed. The motion [18] is granted. Service: 02/27/2019 by clerk. [589070] [LMS] [Entered: 02/27/2019 01:43 PM] (2) |
| Feb 22, 2019 | 20 | Entry of appearance for Thomas W. Krause as of counsel for United States. Service: 02/22/2019 by email. [587943] [19-1364] [Thomas Krause] [Entered: 02/22/2019 11:41 AM] (2) |
| Feb 22, 2019 | 19 | Entry of appearance for Farheena Y. Rasheed as principal counsel for United States. Service: 02/22/2019 by email. [587942] [19-1364] [Farheena Rasheed] [Entered: 02/22/2019 11:39 AM] (2) |
| Feb 22, 2019 | 18 | MODIFIED ENTRY: MOTION of United States to extend the time to 03/21/2019 to file the United States' Unopposed Motion for Extension of Time to File a Notice of Intervention Out of Time. [Consent: unopposed]. Service: 02/22/2019 by email. [587941] [19-1364] [587941]--[Edited 02/27/2019 by CAB to add the correct relief] [Farheena Rasheed] [Entered: 02/22/2019 11:37 AM] (7) |
| Feb 13, 2019 | 17 | Certified list from the United States Patent and Trademark Office. Service: 02/13/2019 by email. Appellant's brief is due 04/15/2019. [585706] --[Edited 02/26/2019 by MMA to revise docket text] [MMA] [Entered: 02/13/2019 04:00 PM] (49) |
| Jan 18, 2019 | 16 | Certificate of Interest for the Appellant Biogen, Inc.. Service: 01/18/2019 by email. [579444] [19-1364] [Rachelle Thompson] [Entered: 01/18/2019 04:33 PM] (3) |
| Jan 18, 2019 | 15 | Docketing Statement for the Appellant Biogen, Inc.. Service: 01/18/2019 by email. [579443] [19-1364] [Rachelle Thompson] [Entered: 01/18/2019 04:32 PM] (4) |
| Jan 18, 2019 | 14 | Entry of appearance for Lyle D. Kossis as of counsel for Appellant Biogen, Inc.. Service: 01/18/2019 by email. [579440] [19-1364] [Lyle Kossis] [Entered: 01/18/2019 04:30 PM] (1) |
| Jan 18, 2019 | 13 | Entry of appearance for Brian D. Schmalzbach as of counsel for Appellant Biogen, Inc.. Service: 01/18/2019 by email. [579438] [19-1364] [Brian Schmalzbach] [Entered: 01/18/2019 04:27 PM] (1) |
| Jan 18, 2019 | 12 | Entry of appearance for Rachelle H. Thompson as principal counsel for Appellant Biogen, Inc.. Service: 01/18/2019 by email. [579435] [19-1364] [Rachelle Thompson] [Entered: 01/18/2019 04:24 PM] (1) |
| Jan 17, 2019 | 11 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [8], ERROR: The contact information contained on the entry of appearance for John Scheibeler does not match the contact information in the attorney's user account. CORRECTION: Please update as needed to ensure the contact information on the entry of appearance and in the user account matches. [579117] [MMA] [Entered: 01/17/2019 04:20 PM] (0) |
| Jan 17, 2019 | 10 | Entry of appearance for Elizabeth Chang as of counsel for Appellee Pfizer, Inc.. Service: 01/17/2019 by email. [579027] [19-1364] [Dimitrios Drivas] [Entered: 01/17/2019 03:06 PM] (2) |
| Jan 17, 2019 | 9 | Entry of appearance for Daniel Ledesma as of counsel for Appellee Pfizer, Inc.. Service: 01/17/2019 by email. [579024] [19-1364] [Dimitrios Drivas] [Entered: 01/17/2019 03:05 PM] (2) |
| Jan 17, 2019 | 8 | Entry of appearance for John Scheibeler as of counsel for Appellee Pfizer, Inc.. Service: 01/17/2019 by email. [579022] [19-1364] [Dimitrios Drivas] [Entered: 01/17/2019 03:04 PM] (2) |
| Jan 17, 2019 | 7 | Entry of appearance for Jeannine Yoo Sano as of counsel for Appellee Pfizer, Inc.. Service: 01/17/2019 by email. [579021] [19-1364] [Dimitrios Drivas] [Entered: 01/17/2019 03:02 PM] (2) |
| Jan 17, 2019 | 6 | Entry of appearance for Dimitrios T. Drivas as principal counsel for Appellee Pfizer, Inc.. Service: 01/17/2019 by email. [579020] [19-1364] [Dimitrios Drivas] [Entered: 01/17/2019 03:01 PM] (2) |
| Jan 17, 2019 | 5 | Certificate of Interest for the Appellee Pfizer, Inc.. Service: 01/17/2019 by email. [579017] [19-1364] [Dimitrios Drivas] [Entered: 01/17/2019 02:59 PM] (3) |
| Jan 17, 2019 | 4 | Docketing Statement for the Appellee Pfizer, Inc.. Service: 01/17/2019 by email. [579014] [19-1364] [Dimitrios Drivas] [Entered: 01/17/2019 02:58 PM] (4) |
| Jan 10, 2019 | 3 | ORDER filed. Notice of the appellant’s constitutional challenge [2] is hereby certified to the Attorney General. No later than 40 days from the date of filing of this order, the Attorney General is directed to inform this court whether the United States intends to intervene in this appeal. Service: 01/10/2019 by clerk. [577361] [NL] [Entered: 01/10/2019 03:05 PM] (2) |
| Jan 7, 2019 | 2 | Notice from Appellant Biogen, Inc. Pursuant to Fed. R. App. 44. Service: 01/07/2019 by email, US mail. [576472] [19-1364] [Keith Orso] [Entered: 01/07/2019 04:20 PM] (4) |
| Jan 4, 2019 | 1 | Appeal docketed. Received: 01/02/2019. [575877] Entry of Appearance due 01/18/2019. Certificate of Interest is due on 01/18/2019. Docketing Statement due 01/18/2019. Certified List due on 02/13/2019. [MMA] [Entered: 01/04/2019 10:01 AM] (49) |
